Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 3
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

453.2000 0.00 (0.00%)

NSE Jun 30, 2025 09:07 AM

28.63% Fall from 52W High

Volume: 84

Aarti Drugs Ltd.

29 Oct 2021, 12:00AM

Result Update:Aarti Drugs

Hold: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

We believe this trend will continue for the upcoming quarters and therefore recommend HOLD rating 0n the stock with a Target Price of Rs 645/share.

Aarti Drugs Ltd. has an average target of 475.00 from 1 broker.